The ongoing impacts of hepatitis C - A systematic narrative review of the literature

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Miller, Emma R ^a   McNally, Stephen ^b   Wallace, Jack ^b   Schlichthorst, Marisa ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Health outcome; Hepatitis C; Social impact

Indexed keywords

ADULT; ATTITUDE TO HEALTH; COST OF ILLNESS; FEMALE; HEPATITIS C; HUMAN; MALE; QUALITATIVE RESEARCH; REVIEW;

ADULT; COST OF ILLNESS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C; HUMANS; MALE; QUALITATIVE RESEARCH;

EID: 84865050297     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-672     Document Type: Review

References (75)

1. Evolving epidemiology of hepatitis C virus. Lavanchy D, Clin Microbial Infect 2011 17 107 115 10.1111/j.1469-0691.2010.03432.x
2. Epidemiology of hepatitis C virus infection in Australia, Chapter 1 in Hepatitis C: an update. Dore GJ, MacDonald M, Law MG, Kaldor JM, Aust Fam Physician 2003 32 2 5 Special feature
3. Canberra: Department of Health and Ageing, Commonwealth of Australia: National Notifiable Diseases Surveillance System [on line database] http://www9.health.gov.au/cda/Source/CDA-index.cfm
4. Geneva: WHO, World Health Organization: Hepatitis C-Fact sheet N°164. 2012 http://www.who.int/mediacentre/factsheets/fs164/en/
5. Chronic Hepatitis C, Chapter 4 in Hepatitis C an update. Batey RG, Aust Fam Physician 2003 32 15 20 Special feature 12647653
6. HCV virology. Eyre N, Beard M, Hepatitis C: an expanding perspective IP Communications, Melbourne, Dore G, Temple-Smith M, Lloyd A, 2009 3 26
7. Farrell GC, Hepatitis C, other liver disorders, and liver health MacLennan and Petty, NSW 2002
8. Now, later or never? Challenges associated with hepatitis treatment. McNally S, Temple-Smith M, Sievert W, Pitts MK, Aust N Z J Public Health 2006 30 422 427 10.1111/j.1467-842X.2006.tb00457.x 17073222 (Pubitemid 44614446)
9. National Centre for HIV Epidemiological and Clinical Research, HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2010 National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW 2010
10. Chronic hepatitis C virus infection. Flamm SL, J Am Med Assoc 2003 289 2413 2417 10.1001/jama.289.18.2413 (Pubitemid 37430175)
11. The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs. Su J, Brook RA, Kleinman NL, Corey-Lisle P, Hepatology 2010 52 436 442 10.1002/hep.23726 20683943
12. Anti-Discrimination Board of New South Wales, C-change: the report of the enquiry into hepatitis C related discrimination Anti-Discrimination Board of New South Wales, Sydney 2001
13. Australians living with and managing hepatitis C. O'Brien AP, Cross WM, Higgs P, Munro I, Bloomer MJ, Chou KR, Issues Ment Health Nurs 2010 31 520 524 10.3109/01612841003629532 20624020
14. Living with hepatitis C: from self-loathing to advocacy. Waller L, Medical Journal of Australia 2004 180 293 294 15012569 (Pubitemid 38372235)
15. Health psychological adjustment to chronic disease. Stanton AL, Revenson TA, Tennen H, Annu Rev Psychol 2007 58 565 592 10.1146/annurev.psych.58.110405. 085615 16930096
16. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience. Roy E, Boudreau J-F, Boivin J-F, Drug Alcohol Depend 2009 102 158 161 10.1016/j.drugalcdep.2009.01.006 19251382
17. High hepatitis C incidence in new injecting drug users: a policy failure? Maher L, Li J, Jalaludin B, Chant KG, Kaldor JM, Aust N Z J Public Health 2007 31 30 35 10.1111/j.1753-6405.2007.00007.x 17333606 (Pubitemid 46380631)
18. Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents. Grebely J, Raffa JD, Lai C, Krajden M, Kerr T, Fischer B, Tyndall MW, J Viral Hepat 2009 16 352 358 10.1111/j.1365-2893.2009.01080.x 19226330
19. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. Sbebl FM, El-Kamary SS, Saleh DA, Abdel-Hamid M, Mikhail N, Allam A, El-Arabi H, Elhenawy I, El-Kafrawy S, El-Daly M, et al. J Med Virol 2009 81 1024 1031 10.1002/jmv.21480 19382251
20. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Dolan KA, Shearer J, White B, Zhou J, Kaldor J, Wodak AD, Addiction 2005 100 820 828 10.1111/j.1360-0443.2005.01050.x 15918812 (Pubitemid 40769826)
21. HCV infection in South Australian prisoners: seroprevalence, seroconversion and risk factors. Miller ER, Bi P, Ryan P, Int J Infect Dis 2009 13 201 208 10.1016/j.ijid.2008.06.011 18790659
22. Diagnosis and 10-year follow-up of a community-based hepatitis C cohort. Yawn BP, Wollan P, Gazzuola L, Kim RW, J Fam Pract 2002 51 135 140 11978211 (Pubitemid 34132625)
23. Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth. Zampino R, Marrone A, Merola A, Trani B, Cirillo G, Karayiannis P, Coppola N, Zappalà R, Utili R, GRuggiero G, Adinolfi LE, J Med Virol 2009 81 2012 2020 10.1002/jmv.21560 19856471
24. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Grebely J, Raffa JD, Lai C, Krajden M, Conway B, Tyndall MW, Can J Gastroenterol 2007 21 447 451 17637948 (Pubitemid 47307717)
25. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and Human Immunodeficiency virus coinfected patients with decompensated cirrhosis. García-García JA, Romero-Gómez M, Girón-González JA, Rivera-Irigoin R, Torre-Cisneros J, Montero JL, González-Serrano M, Andrade RJ, Aguilar-Guisado M, Grilo I, et al. AIDS Res Hum Retroviruses 2006 22 1236 1241 10.1089/aid.2006.22.1236 17209765 (Pubitemid 46095240)
26. Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study. Hansen N, Obel N, Christensen PB, Krarup H, Laursen AL, Clausen MR, Lunding S, Moller A, Schlichting P, Kromann-Andersen H, et al. J Viral Hepat 2009 16 659 665 10.1111/j.1365-2893. 2009.01126.x 19486467
27. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. Bonacini M, Louie S, Bzowej N, Wohl AR, AIDS 2004 18 2039 2045 10.1097/00002030-200410210-00008 15577625 (Pubitemid 39463357)
28. Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia. Melendez-Morales L, Konkle BA, Preiss L, Zhang M, Mathew P, Eyster ME, Goedert JJ, AIDS 2007 21 1631 1636 10.1097/QAD.0b013e32826fb6d9 17630559 (Pubitemid 47075485)
29. Evon DM, Ramcharran D, Belle SH, Terrault NA, Fontana RJ, Fried MW, the Virahep-C Study Group, Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: result of the Virahep-C Study American Journal of Gastroenterology. 2009 Advance on line publication, 29 September 2009
30. Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up. Dalgard O, Bjoro K, Hellum K, Myrvang B, Skaug K, Gutigard G, Belle H, the Construct Group, Eur Addict Res 2002 8 45 49 10.1159/000049487 11818693 (Pubitemid 34701984)
31. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T, Ann Intern Med 2007 146 649 656 17470833 (Pubitemid 351650520)
32. Natural history of post-liver transplantation hepatitis C: a review of factors that may influence its course. Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Williams JW, Rakela J, Vargas HE, Liver Transpl 2009 15 1872 1881 10.1002/lt.21954 19938138
33. Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C. Bizollon T, Pradat P, Mabrut JY, Chevallier M, Adham M, Radenne S, Souquet JC, Ducerf C, Baulieux J, Zoulim F, Trepo C, Am J Transplant 2005 5 1909 1913 10.1111/j.1600-6143.2005.00976.x 15996238 (Pubitemid 41039864)
34. Uncertainty, symptoms, and quality of life in persons with chronic hepatitis. Bailey DE Jr, Landerman L, Barroso J, Bixby P, Mishel MH, Muir AJ, Strickland L, Clipp E, Psychosomatics 2009 50 138 146 10.1176/appi.psy.50.2.138 19377022
35. Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment. Thein HH, Maruff P, Krahn M, Kaldor JM, Koorey DJ, Brew BJ, Dore GJ, HIV Med 2007 8 192 202 10.1111/j.1468-1293.2007.00452.x 17461864 (Pubitemid 46923439)
36. Quality of life in Hepatitis C virus infection: assessment of rural patients living in north-western New South Wales. Gunasekera S, Fraser J, Alexander C, Aust J Rural Health 2008 16 213 220 10.1111/j.1440-1584.2008.00983. x 18652609 (Pubitemid 352044316)
37. Subclinical impairment of brain function in chronic hepatitis C infection. Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P, Wrba F, Madl C, Gangl A, Ferenci P, J Hepatol 2002 37 349 354 10.1016/S0168-8278(02) 00172-1 12175630 (Pubitemid 34969951)
38. Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection. Kramer L, Hofer H, Bauer E, Funk G, Formann E, Steindl-Munda P, Ferenci P, AIDS 2005 19 85 S92 10.1097/01.aids.0000192075.26314.87 16251834
39. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and hepatitis C: Implications for clinical management and future research. Marcellin F, Preau M, Ravaux I, Dellamonica P, Spire B, Carrieri MP, HIV Clin Trials 2007 8 320 327 10.1310/hct0805-320 17956833 (Pubitemid 350103429)
40. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Dalgard O, Egeland A, Skaug K, Vilimas K, Steen T, Hepatology 2004 39 74 80 10.1002/hep.20014 14752825 (Pubitemid 38461469)
41. Chronic hepatitis C virus infection: Does it really impact health-related quality of life? A study in rural Egypt. Schwarzinger M, Dewedar S, Rekacewicz C, Abd Elaziz KM, Fontanet A, Carrat F, Mohamed MK, Hepatology 2004 40 1434 1441 10.1002/hep.20468 15565610 (Pubitemid 39657019)
42. Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. Fontana RJ, Hussain KB, Schwartz SM, Moyer CA, Su GL, Lok ASF, J Hepatol 2002 36 401 407 10.1016/S0168-8278(01)00280-X 11867185 (Pubitemid 34194801)
43. Biopsychosocial predictors of fatigue in chronic hepatitis C. Hilsabeck RC, Hassanein TI, Perry W, J Psychosom Res 2005 58 173 178 10.1016/j.jpsychores. 2004.07.003 15820845
44. Therapy expectations and physical co morbidity affect quality of life in chronic hepatitis C virus infection. Taliani G, Rucci P, Biliotti E, Cirrincione L, Aghemo A, Alberti A, Almasio PL, Bartolozzi D, Caporaso N, Coppola R, et al. J Viral Hepat 2007 14 875 882 18070291 (Pubitemid 350211410)
45. Quality of life after liver transplantation for hepatitis C infection. Dudley T, Chaplin D, Clifford C, Mutimer DJ, Qual Life Res 2007 16 1299 1308 10.1007/s11136-007-9244-y 17665316 (Pubitemid 47459883)
46. Understanding social stigma in women with hepatitis C. Grundy G, Beeching N, Nurs Stand 2004 19 35 39 15521414
47. Psychosocial issues in hepatitis C: a qualitative analysis. Janke EA, McGraw S, Garcia-Tsao G, Fraenkel L, Psychosomatics 2008 49 494 501 10.1176/appi.psy.49.6.494 19122126
48. Living with hepatitis C and treatment: the personal experiences of patients. Sgorbini M, O'Brien L, Jackson D, J Clin Nurs 2009 18 2282 2291 10.1111/j.1365-2702.2009.02806.x 19583661
49. The lived experience of men and women with hepatitis C: implications for support needs and health information. Temple-Smith M, Gifford S, Stoové M, Aust Health Rev 2004 27 46 56 10.1071/AH042720046 15525236
50. Social stigmatization and hepatitis C virus infection. Zacks S, Beavers K, Theodore D, Dougherty K, Batey B, Shumaker J, Galanko J, Shrestha R, Fried MW, Journal of Clinincal Gastroenterology 2006 40 220 224 10.1097/00004836- 200603000-00009 (Pubitemid 44309554)
51. Lifestyle changes and beliefs regarding disease severity in patients with chronic hepatitis C. Castera L, Constant A, Bernard PH, de Ledinghen V, Couzigou P, J Viral Hepat 2006 13 482 488 10.1111/j.1365-2893.2005.00719.x 16792542
52. Impact of hepatitis C virus infection on lifestyle. Scognamiglio P, Galati V, Navarra A, Longo MA, Aloisi MS, Antonini MG, Puoti M, Almasio PL, Ippolito G, Girardi E, World J Gastroenterol 2007 13 2722 2726 17569142 (Pubitemid 46958729)
53. Hepatitis C meaning and preventive strategies among street-involved young injection drug users in Montréal. Roy E, Nonn É Haley N, Cox J, Int J Drug Policy 2007 18 397 405 10.1016/j.drugpo.2007.02.005 17854728 (Pubitemid 47374504)
54. Exploring risk perceptions and behaviour of homeless injecting drug users diagnosed with hepatitis C. Wright NMJ, Tompkins CNE, Jones L, Health Soc Care Community 2005 13 75 83 10.1111/j.1365-2524.2005.00552.x 15717909 (Pubitemid 40131805)
55. Living with chronic hepatitis C means 'you just haven't got a normal life any more'. Conrad S, Garrett LE, Cooksley WGE, Dunne MP, MacDonald GA, Chronic Ilness 2006 2 121 131 (Pubitemid 44014758)
56. Emotional stress, psychosocial variables and coping associated with hepatitis C virus and human immunodeficiency virus infections in intravenous drug users. Grassi L, Satriano J, Serra A, Biancosino B, Zotos S, Sighinolfi L, Ghinelli F, Psychother Psychosom 2002 71 342 349 10.1159/000065993 12411769 (Pubitemid 36151510)
57. Living with hepatitis C: qualitative interviews with hepatitis C-infected veterans. Groessl EJ, Weingart KR, Kaplan RM, Clark JA, Gifford AL, Ho SB, J Gen Intern Med 2008 23 1959 1965 10.1007/s11606-008-0790-y 18807097
58. Resilient coping: applying adaptive responses to prior adversity during treatment for hepatitis C infection. Hopwood M, Treloar C, J Health Psychol 2008 13 17 27 10.1177/1359105307084308 18086714
59. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Golden J, O'Dwyer AM, Conroy RM, Gen Hosp Psychiatry 2005 27 431 438 10.1016/j.genhosppsych.2005.06.006 16271658 (Pubitemid 41566070)
60. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD, Hepatology 2002 35 433 439 10.1053/jhep.2002. 30688 11826420 (Pubitemid 34106386)
61. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, Heathcoate EJ, Hepatology 2005 41 801 808 10.1002/hep.20635 15793853 (Pubitemid 40462942)
62. Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Piche T, Gelsi E, Schneider SM, Hebuterne X, Giudicelli J, Ferrua B, Laffont C, Benzaken S, Hastier P, Montoya ML, et al. Gut 2002 51 434 439 10.1136/gut.51.3.434 12171970
63. Impact of a positive hepatitis C diagnosis on homeless injecting drug users: a qualitative study. Tompkins CN, Wright NM, Jones L, Br J Gen Pract 2005 55 263 268 15826432 (Pubitemid 40520901)
64. Psychological impact of chronic hepatitis C: Comparison with other stressful life events and chronic diseases. Castera L, Constant A, Bernard PH, de Ledinghen V, Couzigou P, World J Gastroenterol 2006 12 1545 1550 16570346
65. Chronic illness experiences, clinical markers and living with hepatitis C. Sutton R, Treloar C, J Health Psychol 2007 12 330 340 10.1177/ 1359105307074278 17284496 (Pubitemid 46198586)
66. Troubling biographical disruption: narratives of unconcern about hepatitis C diagnosis. Harris M, Sociol Health Illn 2009 31 1028 1042 10.1111/j.1467-9566.2009.01172.x 19659739
67. "Eyes Wide Shut": narratives of women living with hepatitis C in Australia. Crockett B, Gifford SM, Women Health 2004 39 117 137 10.1300/J013v39n04-07 15691088 (Pubitemid 40011875)
68. Illness-related stigma, mood and adjustment to illness in persons with hepatitis C. Golden J, Conroy RM, O'Dwyer AM, Golden D, Hardouin JB, Soc Sci Med 2006 63 3188 3198 10.1016/j.socscimed.2006.08.005 17010490 (Pubitemid 44648500)
69. The construction of hepatitis C as a chronic illness. Paterson BL, Butt G, McGuinness L, Moffat B, Clin Nurs Res 2006 15 209 224 10.1177/ 1054773806288569 16801360 (Pubitemid 43953823)
70. Hepatitis C and injecting-related discrimination in New South Wales, Australia. Hopwood M, Treloar C, Bryant J, Drugs-Education Prevention and Policy 2006 13 61 75 10.1080/09687630500481150 (Pubitemid 43663701)
71. Living with the stigma of hepatitis C. Butt G, Paterson BL, McGuinness LK, West J Nurs Res 2008 30 204 221 17630381
72. Living with hepatitis C: the medical encounter. Harris M, N Z Sociol 2005 20 4 19
73. HCV treatment decision-making substance use experiences and hepatitis C treatment decision-making among HIV/HCV Coinfected Adults. Ogawa LM, Bova C, Subst Use Misuse 2009 44 915 933 10.1080/10826080802486897 19440928
74. "Look, I'm fit, I'm positive and I'll be all right, thank you very much": coping with hepatitis C treatment and unrealistic optimism. Treloar C, Hopwood M, Psychol Health Med 2008 13 360 366 10.1080/13548500701477532 18569903 (Pubitemid 351882279)
75. New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals. Seden K, Back D, Saye Khoo S, J Antimicrob Chemother 2010 65 1079 1085 10.1093/jac/dkq086 20335191